7-octadecynoic acid

7-octadecynoic acid is a lipid of Fatty Acyls (FA) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 19785 references associated with 7-octadecynoic acid in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.


Here are additional resources we collected from PubChem and MeSH for 7-octadecynoic acid

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 7-octadecynoic acid

MeSH term MeSH ID Detail
Vestibulocochlear Nerve Diseases D000160 1 associated lipids
Acromegaly D000172 6 associated lipids
Actinobacillus Infections D000189 4 associated lipids
Actinomycosis D000196 2 associated lipids
Addison Disease D000224 3 associated lipids
Adenocarcinoma D000230 166 associated lipids
Adrenal Hyperplasia, Congenital D000312 2 associated lipids
Albuminuria D000419 18 associated lipids
Alzheimer Disease D000544 76 associated lipids
Angina, Unstable D000789 14 associated lipids
Angioid Streaks D000793 1 associated lipids
Ankylosis D000844 1 associated lipids
Aortic Diseases D001018 11 associated lipids
Arteriosclerosis D001161 86 associated lipids
Arthritis D001168 41 associated lipids
Arthritis, Experimental D001169 24 associated lipids
Arthritis, Rheumatoid D001172 3 associated lipids
Arthropathy, Neurogenic D001177 1 associated lipids
Atrial Fibrillation D001281 16 associated lipids
Autoimmune Diseases D001327 27 associated lipids
Biliary Atresia D001656 4 associated lipids
Body Weight D001835 333 associated lipids
Bone Diseases, Developmental D001848 2 associated lipids
Bone Diseases, Endocrine D001849 1 associated lipids
Bone Diseases, Metabolic D001851 9 associated lipids
Bone Neoplasms D001859 5 associated lipids
Bone Resorption D001862 7 associated lipids
Cachexia D002100 21 associated lipids
Calcinosis D002114 5 associated lipids
Carcinoid Heart Disease D002275 1 associated lipids
Carcinoma D002277 18 associated lipids
Carcinoma, Non-Small-Cell Lung D002289 72 associated lipids
Carcinoma, Papillary D002291 3 associated lipids
Carcinosarcoma D002296 7 associated lipids
Cardiovascular Diseases D002318 24 associated lipids
Celiac Disease D002446 16 associated lipids
Brain Ischemia D002545 89 associated lipids
Cherubism D002636 1 associated lipids
Chondroblastoma D002804 1 associated lipids
Chondrocalcinosis D002805 1 associated lipids
Chronic Disease D002908 7 associated lipids
Cleidocranial Dysplasia D002973 1 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Coronary Artery Disease D003324 47 associated lipids
Coronary Disease D003327 70 associated lipids
Crohn Disease D003424 12 associated lipids
Cryptosporidiosis D003457 3 associated lipids
Cystic Fibrosis D003550 65 associated lipids
Dengue D003715 2 associated lipids
Dental Occlusion, Traumatic D003769 1 associated lipids
Per page 10 20 50 100 | Total 298

All references with 7-octadecynoic acid

Download all related citations
Per page 10 20 50 100 | Total 4091
Authors Title Published Journal PubMed Link
Gautam J et al. An isoflavone cladrin prevents high-fat diet-induced bone loss and inhibits the expression of adipogenic gene regulators in 3T3-L1 adipocyte. 2016 J. Pharm. Pharmacol. pmid:27265669
Owen S et al. Importance of osteoprotegrin and receptor activator of nuclear factor κB in breast cancer response to hepatocyte growth factor and the bone microenvironment in vitro. 2016 Int. J. Oncol. pmid:26781475
Maser RE et al. Osteopontin and osteoprotegerin levels in type 2 diabetes and their association with cardiovascular autonomic function. 2016 J. Diabetes Complicat. pmid:26775555
Gottesman GS et al. Auricular ossification: A newly recognized feature of osteoprotegerin-deficiency juvenile Paget disease. 2016 Am. J. Med. Genet. A pmid:26762549
Totoson P et al. Endothelial Dysfunction in Rheumatoid Arthritis: Mechanistic Insights and Correlation with Circulating Markers of Systemic Inflammation. 2016 PLoS ONE pmid:26761790
Kuroda Y et al. Osteoprotegerin Regulates Pancreatic β-Cell Homeostasis upon Microbial Invasion. 2016 PLoS ONE pmid:26751951
Wang HL et al. Protein biomarkers and microbial profiles in peri-implantitis. 2016 Clin Oral Implants Res pmid:26424287
Iezaki T et al. The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption. 2016 J. Bone Miner. Res. pmid:26391411
Biscetti F et al. RANK/RANKL/OPG pathway: genetic association with history of ischemic stroke in Italian population. 2016 Eur Rev Med Pharmacol Sci pmid:27874938
Liu FQ et al. Effects of Salt Loading on Plasma Osteoprotegerin Levels and Protective Role of Potassium Supplement in Normotensive Subjects. 2016 Circ. J. pmid:27867157
Kim CS et al. Association of Serum Osteoprotegerin Levels with Bone Loss in Chronic Kidney Disease: Insights from the KNOW-CKD Study. 2016 PLoS ONE pmid:27855207
Li XJ et al. Bergapten exerts inhibitory effects on diabetes-related osteoporosis via the regulation of the PI3K/AKT, JNK/MAPK and NF-κB signaling pathways in osteoprotegerin knockout mice. 2016 Int. J. Mol. Med. pmid:27840967
Zhou J and Zhao Y Osteoprotegerin Gene (OPG) Polymorphisms Associated with Peri-implantitis Susceptibility in a Chinese Han Population. 2016 Med. Sci. Monit. pmid:27828936
Ostrowska Z et al. TGF-β1, bone metabolism, osteoprotegerin, and soluble receptor activator of nuclear factor-kB ligand in girls with anorexia nervosa. 2016 Endokrynol Pol pmid:27828689
He M et al. Effect of glucocorticoids on osteoclast function in a mouse model of bone necrosis. 2016 Mol Med Rep pmid:27277157
Ye C et al. [Effect of MT01/PEN complexes on the expression of osteoprotegerin and receptor activator of nuclear factor κB ligand in human osteoblast-like cell line MG63]. 2016 Hua Xi Kou Qiang Yi Xue Za Zhi pmid:27266195
Bernardi S et al. Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease. 2016 Biomed Res Int pmid:27200369
Wei CC et al. Icariin Prevents Cartilage and Bone Degradation in Experimental Models of Arthritis. 2016 Mediators Inflamm. pmid:27199510
Usategui-Martín R et al. VAV3 Gene Polymorphism Is Associated with Paget's Disease of Bone. 2016 Genet Test Mol Biomarkers pmid:27172236
Li B et al. Unfractionated Heparin Promotes Osteoclast Formation in Vitro by Inhibiting Osteoprotegerin Activity. 2016 Int J Mol Sci pmid:27110777

Table of Content